Atlas Trials

An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies

Clinical trial NCT03521895 · COMPLETED

Trial details

NCT number
NCT03521895
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Macular Degeneration
Start date
2018-05-01
Primary completion
2018-11-30
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.